At the World Glaucoma Congress (WGC) in 2019, Dr Ike Ahmed (Toronto, Canada) presents the results of the STAR-I first-in-human trial for the MINIject MIGS device at 1 year. Two year final results will be presented at the European Glaucoma Society (EGS) meeting in Brussels in May 2020.